Skip to main content
Premium Trial:

Request an Annual Quote

UBS Downgrades Cepheid Stock to 'Neutral'

NEW YORK (GenomeWeb News) — Investment bank UBS today downgraded Cepheid’s stock to ‘neutral’ from ‘buy.’
 
Cepheid’s shares have risen 135 percent since the start of the year and reached a new 52-week high yesterday when they reached $20.29. Shares closed at $20.17 that day.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.